Merck files for FDA approval of Keytruda in lung cancer

(Reuters) - Merck & Co Inc said on Sunday it has submitted an application to the U.S. Food and Drug Administration for its drug Keytruda as a treatment for advanced non-small cell lung cancer, the most common form of the disease.

from

• غرد
• مشاركة
• إضافة